CBRE Q1 2026 Earnings Massive EPS Beat Masks Tepid Market Reception PDEX Q1 2026 Earnings EPS Surges 8975 Above Estimates Amid Stock Decline MaxCyte Q1 2026 Earnings EPS Beat Highlights Operational Cost Discipline Amid Revenue Disclosure Gaps Dave Busters PLAY Q1 2026 Earnings Massive EPS Miss on Estimated Loss But Stock Rises Amid Strategic Shifts enVVeno Medical NVNO Q3 2025 Earnings NarrowerThanExpected Loss Signals Cost Discipline Progress BioAge Labs Q1 2026 Earnings Narrower Loss Delivers Positive Surprise as PreRevenue Biotech Advances Pipeline